| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/29/2002 | WO2002066058A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 08/29/2002 | WO2002066044A2 Method for dendritic cells based immunotherapy of tumors using combination therapy |
| 08/29/2002 | WO2002066041A1 Natural composition |
| 08/29/2002 | WO2002066040A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 08/29/2002 | WO2002066038A1 Treatment of refractory tumors using epothilone derivatives |
| 08/29/2002 | WO2002066030A1 Medicinal compositions comprising diclofenac and ornoprostil |
| 08/29/2002 | WO2002066028A2 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 08/29/2002 | WO2002066020A2 Modulation of gsk-3beta activity and its different uses |
| 08/29/2002 | WO2002066019A2 Cancer treatment |
| 08/29/2002 | WO2002066016A2 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine |
| 08/29/2002 | WO2002066014A2 Cubic liquid crystalline compositions and methods for their preparation |
| 08/29/2002 | WO2002066002A2 Pharmaceutical formulation |
| 08/29/2002 | WO2002065981A2 Chemotherapeutic composition using calcium phosphate paste |
| 08/29/2002 | WO2002047668A3 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides |
| 08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002039991A3 Prevention of development of dyskinesias |
| 08/29/2002 | WO2002037937A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002028346A3 Association of the cb1 receptor antagonist and sibutramin, for treating obesity |
| 08/29/2002 | WO2002022795A3 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2002015894A3 Use of vitamin d derivatives as bone resorption inhibitors |
| 08/29/2002 | WO2002010403A3 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 08/29/2002 | WO2002008256A3 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 08/29/2002 | WO2001096547A3 Human kinases |
| 08/29/2002 | WO2001090758A3 Diagnosis of alzheimer's disease ldl receptor protein-1 |
| 08/29/2002 | WO2001087288A8 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists |
| 08/29/2002 | WO2001085944A3 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 08/29/2002 | WO2001085154A3 Method of treating immune pathologies with low dose estrogen |
| 08/29/2002 | WO2001077338A3 Human protein kinases and protein kinase-like enzymes |
| 08/29/2002 | WO2001071342A3 Identification of mast cell/basophil activation inhibitors |
| 08/29/2002 | WO2001070206A3 Combination of lecithin with ascorbic acid |
| 08/29/2002 | WO2001068848A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/29/2002 | WO2001068053A3 Methods and compositions for treating and preventing posterior segment ophthalmic disorders |
| 08/29/2002 | WO2001061055A3 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 08/29/2002 | WO2001060408A3 Microcompetiton and human disease |
| 08/29/2002 | WO2001037785A9 Novel methods and compositions involving opioids and antagonists thereof |
| 08/29/2002 | WO2001032158A3 Pharmaceutical composition comprising a combination of metformin and another antidiabetic agent |
| 08/29/2002 | WO2001008670A3 Methods and compositions for alleviating stuttering |
| 08/29/2002 | WO2001005373A9 Methods and apparatus for preparation of lipid vesicles |
| 08/29/2002 | WO2001000247A9 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 08/29/2002 | WO2000066737A9 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY |
| 08/29/2002 | WO2000061606A9 Novel human voltage-gated potassium channel |
| 08/29/2002 | WO2000059515A9 Immunomodulating polymers |
| 08/29/2002 | WO2000037502A9 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/29/2002 | WO2000034474A9 Growth factor homolog zvegf3 |
| 08/29/2002 | WO2000010981A9 Quinazoline derivatives |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120947 Protein-protein interactions in neurodegenerative disorders |
| 08/29/2002 | US20020120121 Antisense therapy of cancer; Inhibitors of Apoptosis Proteins (IAPs) and an additional related antiapoptotic protein, NAIP; |
| 08/29/2002 | US20020120102 Native Arg-Gly-Asp (RGD) motif has been deleted or has been replaced by an amino acid sequence having no integrin- binding activity, or an integrin-binding amino acid sequence other than RGD which contains aspartic acid or glutamic acid |
| 08/29/2002 | US20020120100 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents |
| 08/29/2002 | US20020120003 Methods for decreasing beta amyloid protein |
| 08/29/2002 | US20020120002 2-tri-halo-1-methyl-N-acetyl-5-methoxytryptamine and a carrier |
| 08/29/2002 | US20020120001 Compositions containing tryptamines, cartenoids and tocotrienols and having synergistic antioxidant effect |
| 08/29/2002 | US20020119990 Liposomal camptothecins and uses thereof |
| 08/29/2002 | US20020119987 Analgesics, anesthetic; side effect reduction |
| 08/29/2002 | US20020119982 Antiviral azaindole derivatives |
| 08/29/2002 | US20020119977 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 08/29/2002 | US20020119974 Administering guanosine cyclic 3',5'-monophosphate; phosphodiesterase inhibitor |
| 08/29/2002 | US20020119972 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases |
| 08/29/2002 | US20020119967 Autoimmune diseases; administering phosphodiesterases inhibitor |
| 08/29/2002 | US20020119955 Modified prodrug forms of AP/AMP |
| 08/29/2002 | US20020119952 Composition and method of treating arthritis |
| 08/29/2002 | US20020119950 Administering mixture of aminosugar with ergothionine, diacetin, arachadonic acid and tatracyclic antibiotic |
| 08/29/2002 | US20020119933 Administering ribose; cardiovascular disorders |
| 08/29/2002 | US20020119928 Mixture of colostrum, lactoferrin, pectin and glucan |
| 08/29/2002 | US20020119924 Combination therapy using a TNF binding protein for treating TNF-mediated diseases |
| 08/29/2002 | US20020119923 Administering macrophage derived compound |
| 08/29/2002 | US20020119912 Synergistic mixture; therapy for psychological disorders |
| 08/29/2002 | US20020119548 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/29/2002 | US20020119518 Peptide for use in treatment and diagnosis of heart defects |
| 08/29/2002 | US20020119517 Detection of modulators of body weight; obtain cell samples, monitor expression of preferenial genes, incubate with modulators, compare to control, monitor adjustment in body weight |
| 08/29/2002 | US20020119510 Enzymatic polypeptide for use in screening bactericides |
| 08/29/2002 | US20020119504 Antibody or antigen-binding sequences for use in the treatment of inflammatory bowel disease |
| 08/29/2002 | US20020119502 Screening drugs for use in the treatment of mammary gland cancer; obtain animal, inject or orally administer anticarcinogeneic agent, monitor animal for development of cancer |
| 08/29/2002 | US20020119479 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant GPIIIa and/or variant GPIIb allele |
| 08/29/2002 | US20020119430 Hypnotist referral network |
| 08/29/2002 | US20020119207 For decontaminating areas, samples, solutions, and foodstuffs colonized or otherwise infected by pathogens and microorganisms |
| 08/29/2002 | US20020119202 For therapy of cancer and other angiogenic-dependent diseases |
| 08/29/2002 | US20020119198 For manufacture of a medicament for therapeutic treatment, such as steroidal, antifungal, antibacterial, or anticancer treatment |
| 08/29/2002 | US20020119187 Useful to induce analgesia |
| 08/29/2002 | US20020119186 Establishing a drug depot in tissues under the user's skin surface by applying a transdermal drug delivery system on a user's skin; allowing transdermal drug delivery system to be applied on skin area without heating; placing heating source |
| 08/29/2002 | US20020119181 Nutritional composition made from conventional foods for mixing onsite in a blender and treating patients with hepatic disorders |
| 08/29/2002 | US20020119159 Administering to a mucosal surface inducing antigen and mucosal binding component in unconjugated form for inducing sustained immunological tolerance in an individual to a target antigen |
| 08/29/2002 | US20020119158 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 08/29/2002 | US20020119153 Antibody conjugate formulations for selectively inhibiting VEGF |
| 08/29/2002 | US20020119151 CD154 blockade therapy for therapeutic protein inhibitor syndrome |
| 08/29/2002 | US20020119150 Administering an effective amount of a CD40:CD154 binding interrupter to primate graft recipient for therapy of rejection of tissue graft |
| 08/29/2002 | US20020119148 ErbB4 antagonists |
| 08/29/2002 | US20020119144 Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
| 08/29/2002 | US20020119136 Antimicrobial peroxidase compositions |
| 08/29/2002 | US20020119128 Graft acceptance through manipulation of thymic regeneration |
| 08/29/2002 | US20020119119 Administering natural killer cell activating cytokine or flavonoid, wherein cytokine is not IL-2 or IFN-alpha; administering histamine or serotonin or H2 receptor agonists to inhibit production or release of hydrogen peroxide |
| 08/29/2002 | US20020119109 Cosmetic and dermatological preparation for the removal of sebum |
| 08/29/2002 | US20020119107 Method for protecting and restoring skin using selective MMP inhibitors |
| 08/29/2002 | US20020119104 Treatment of mucositis |
| 08/29/2002 | US20020119077 Liquid chemical distribution method and apparatus |
| 08/29/2002 | DE10065478C1 Kreatin/Citronensäure-Verbindung, Verfahren zu ihrer Herstellung und Verwendung Creatine / citric acid combination, processes for their preparation and use |
| 08/29/2002 | CA2737095A1 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 08/29/2002 | CA2473197A1 Novel human protease and polynucleotides encoding the same |